Proteomic analyses of different human tumour-derived chaperone-rich cell lysate (CRCL) anti-cancer vaccines reveal antigen content and strong similarities amongst the vaccines along with a basis for CRCL's unique structure: CRCL vaccine proteome leads to unique structure

A novel multiplex-protein array for serum diagnostics of colon cancer: a case–control study

(2012) Stefanie Bünger et al.   BMC CANCER

Elevated expression of chloride intracellular channel 1 is correlated with poor prognosis in human gliomas

(2012) Liang Wang et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Influenza virosomes as a vaccine adjuvant and carrier system

(2011) Christian Moser et al.   Expert Review of Vaccines

Developments in virus-like particle-based vaccines for infectious diseases and cancer

(2011) Luigi Buonaguro et al.   Expert Review of Vaccines

Extracellular heat shock protein 90 plays a role in translocating chaperoned antigen from endosome to proteasome for generating antigenic peptide to be cross-presented by dendritic cells

(2011) J. Oura et al.   INTERNATIONAL IMMUNOLOGY

Selective expression of S100A11 in lung cancer and its role in regulating proliferation of adenocarcinomas cells

(2011) Juanting Hao et al.   MOLECULAR AND CELLULAR BIOCHEMISTRY

Immunoproteomics of HER2-Positive and HER2-Negative Breast Cancer Patients with Positive Lymph Nodes

(2011) Zahra Mojtahedi et al.   OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY

Serum Cellular Apoptosis Susceptibility Protein Is a Potential Prognostic Marker for Metastatic Colorectal Cancer

(2010) Chin-Shaw Stella Tsai et al.   AMERICAN JOURNAL OF PATHOLOGY

Transcriptomic signature of cell lines isolated from canine mammary adenocarcinoma metastases to lungs

(2010) M. Król et al.   JOURNAL OF APPLIED GENETICS

Superior Antitumor Response Induced by Large Stress Protein Chaperoned Protein Antigen Compared with Peptide Antigen

(2010) X. Y. Wang et al.   JOURNAL OF IMMUNOLOGY

Higher Prevalence of Secretory CSE1L/CAS in Sera of Patients with Metastatic Cancer

(2009) M.-C. Tung et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Heat shock proteins and immunity: Application of hyperthermia for immunomodulation

(2009) Toshihiko Torigoe et al.   INTERNATIONAL JOURNAL OF HYPERTHERMIA

Serum S100A6 Concentration Predicts Peritoneal Tumor Burden in Mice with Epithelial Ovarian Cancer and Is Associated with Advanced Stage in Patients

(2009) Bih-Rong Wei et al.   PLoS One

Identification of tumor antigens that elicit a humoral immune response in breast cancer patients' sera by serological proteome analysis (SERPA)

(2008) Bechr Hamrita et al.   CLINICA CHIMICA ACTA

Expression of chloride intracellular channel protein 1 (CLIC1) and tumor protein D52 (TPD52) as potential biomarkers for colorectal cancer

(2008) Darinka Todorova Petrova et al.   CLINICAL BIOCHEMISTRY

Differential capacity of chaperone-rich lysates in cross-presenting human endogenous and exogenous melanoma differentiation antigens

(2008) Elke Bleifuss et al.   INTERNATIONAL JOURNAL OF HYPERTHERMIA

Recent Advances in Cancer Vaccines: An Overview

(2008) K. Itoh et al.   JAPANESE JOURNAL OF CLINICAL ONCOLOGY

Phase III Comparison of Vitespen, an Autologous Tumor-Derived Heat Shock Protein gp96 Peptide Complex Vaccine, With Physician's Choice of Treatment for Stage IV Melanoma: The C-100-21 Study Group

(2008) Alessandro Testori et al.   JOURNAL OF CLINICAL ONCOLOGY

An adjuvant autologous therapeutic vaccine (HSPPC-96; vitespen) versus observation alone for patients at high risk of recurrence after nephrectomy for renal cell carcinoma: a multicentre, open-label, randomised phase III trial

(2008) Christopher Wood et al.   LANCET